The EN.10/TAPER study has opened to recruitment in Australia, after activating its first site - Westmead Hospital, NSW. This trial explores ways to treat early-stage endometrial cancers with a focus on minimising side effects and costs. [...]
Immunotherapy is rapidly emerging as a promising cancer treatment. Unfortunately, endometrial cancer patients currently lack access to this innovative approach. In response to the rising cases of endometrial cancer globally, DOMENICA is addressing the need to [...]
2,200 ANZ women are diagnosed with ovarian cancer every year, and less than half will survive beyond five years. ANZGOG’s IGNITE trial is testing how effective a new treatment is for patients with relapsed high grade [...]
February marks Ovarian Cancer Awareness Month around the globe. Annually in ANZ, approximately 2,200 women face a life-altering diagnosis of ovarian cancer, and less than half will survive five years. Every year, from 1 February to [...]
ANZGOG invites its members to nominate colleagues/trial teams who you believe deserve recognition for their commitment to ANZGOG's mission. The successful award recipients will be announced at the ANZGOG 2024 Annual Scientific Meeting conference dinner, [...]
Patient involvement in research within the Gynecologic Cancer InterGroup: A call to action for a systematic approach: Results from a survey Patient involvement in clinical research development has gradually expanded over the last two decades, creating [...]
ANZGOG has awarded four Fund for New Research (FFNR) grants for 2023. This year's grant round received 18 applications, each aligned with ANZGOG's research program areas of focus. Grants were awarded to: $32,569 [...]
If you are a GP, practice nurse, oncologist, oncology nurse, menopause specialist, oncology surgeon, surgical nurse, gynaecological oncologist, or pharmacist, ANZGOG invites you to take part in this study. ANZGOG is supporting this study which [...]
People with a lived experience of gynaecological cancers are the centre of everything we do, whether that is designing clinical trials, advocating for research funding, or educating the next generation of health professionals. ANZGOG’s Community Engagement [...]
The XPORT-EC-042 study is open to recruitment in Australia, after Border Medical Oncology Research Unit and Peter MacCallum Cancer Centre were activated. The trial is led by Karyopharm Therapeutics (Global Sponsor), in collaboration with ANZGOG, European [...]
Australia New Zealand Gynaecological Oncology Group www.anzgog.org.au
Level 6, Lifehouse, 119-143 Missenden Road Camperdown NSW 2050 T:+61 2 8071 4880
E: contact@anzgog.org.au © 2024 ANZGOG | Copyright | Disclaimer | ANZGOG Policies | Whistleblower
Virtually every advance in cancer survival has been made on the back of clinical trials.
As the peak, national gynaecological cancer clinical trials organisation for Australia and New Zealand, ANZGOG‘s purpose is to improve outcomes and quality of life for women with gynaecological cancer by conducting research.
We conduct and promote clinical trials and undertake multidisciplinary research into the causes, prevention and treatments of gynaecological cancers.
Research Community Volunteers will have the opportunity to contribute to ANZGOG research at every stage of the development process.
Community volunteers will lend their voices to research discussions sharing their personal perspective and representing the broader views of people with lived experience of gynaecological cancer.
Opportunities range from sharing your lived experience as a participant on a research grant working party or a Trial Management Committee, through to Research Advisor and Expert roles requiring additional levels of education and expertise in research analysis.
Gynaecological cancer research is critically needed but critically underfunded. WomenCan is the fundraising arm of ANZGOG, supporting ANZGOG by funding our programs to improve life for women with gynaecological cancer.
WomenCan’s mission is to engage the community to fund pioneering discoveries that will enable women with a gynaecological cancer to live better and live longer.
WomenCan believes the power of the collective, united in a common purpose, can make a real difference in the lives of women with gynaecological cancers.
ANZGOG’s Survivors Teaching Students (STS) Program is a ground-breaking volunteer program that brings gynaecological cancer survivors and caregivers into the classrooms of health professional students to teach them about women’s experiences with the diseases.
Survivors and caregivers are in a unique position to help students understand the ‘lived experience’ of a gynaecological cancer, including the psychosocial impact, and the importance of timely diagnosis, good health communication and compassionate care.
By joining STS and sharing your story, you will have the opportunity to impact the future care of women diagnosed with a gynaecological cancer, with participating students reporting not only increased understanding of gynaecological cancers but also a deeper understanding of the patient experience to take forward into their practice.
Since the program began at ANZGOG in 2017, our volunteers have shared their stories with more than 11,000 students across Australia and New Zealand.
